VIVO Cannabis™ Announces Third Quarter 2020 Results

Net revenue for Q3 2020 was $7.5 million and Q3 2020 year-to-date net revenue was $25.1 million, an increase of over 50% compared with the same period last year Restructured $27 million in current liabilities, and extended remaining 6% convertible debt of $6.6 million to September 15, 2022 Streamlined and consolidated operations expected to result in increased economies of scale and expected costContinue reading “VIVO Cannabis™ Announces Third Quarter 2020 Results”

VIVO Cannabis™ Streamlines Operations

Rightsizing of Napanee Organization Board and Leadership Changes TORONTO, Oct. 20, 2020 /CNW/ – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“)today announced immediate steps to streamline operations and changes to the Board and Leadership Team. Organizational Rationalization, including an 18% Reduction in Headcount The Company is dedicated to delivering differentiated cannabis products and services while carefully managing expenses,Continue reading “VIVO Cannabis™ Streamlines Operations”

VIVO Cannabis™ Announces Approval of $50 Million Base Shelf Prospectus

TORONTO, Oct. 6, 2020 /CNW/ – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) announces that it has filed a short form base shelf prospectus (the “Shelf Prospectus“) with securities regulatory authorities in each province of Canada. The Shelf Prospectus will enable the Company to offer common shares, debt securities, convertible securities, subscription receipts, warrants, units or anyContinue reading “VIVO Cannabis™ Announces Approval of $50 Million Base Shelf Prospectus”

VIVO Cannabis™ Begins Largest Harvest in Company’s History

TORONTO, Oct. 5, 2020 /CNW/ – VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company“) today announced it has begun its 2020 season harvest at its Kimmetts facility in Napanee, Ontario, the largest in the Company’s history. “I am pleased to say that this year’s crop has exceeded our expectations, with some of our plants reaching a height ofContinue reading “VIVO Cannabis™ Begins Largest Harvest in Company’s History”

VIVO Cannabis™ Completes Debenture Refinancing

 – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) today announced that it has completed its previously announced partial prepayment, conversion and amendment of unsecured convertible debentures (the “Debentures“). As a result, VIVO now has $6.6 million in outstanding Debentures due September 15, 2022 and 328.7 million common shares (each, a “Share”) outstanding on an undiluted basis. “One ofContinue reading “VIVO Cannabis™ Completes Debenture Refinancing”

VIVO Cannabis™ Announces Agreement to Amend Outstanding Debentures

 – VIVO Cannabis Inc. (TSX: VIVO) (“VIVO” or the “Company“) announces that the holders of its 6% unsecured convertible debentures dated February 28, 2018 (each, a “Debenture” and collectively, the “Debentures“), due on February 28, 2021, have approved certain amendments to the Debentures by way of extraordinary resolution of the holders. “We are pleased to have reached an agreement that reducesContinue reading “VIVO Cannabis™ Announces Agreement to Amend Outstanding Debentures”

VIVO Cannabis™ Announces Second Quarter 2020 Results

Net revenue of $9.4 million – an increase of 15% over Q1 2020 and 79% over Q2 2019 Achieved 68% Ontario retail market share in the concentrates category, including first-to-market shatter by Fireside™ X Entered product supply and clinical services agreements with Medical Cannabis by Shoppers™ Canna Farms™ is the fourth most recognized cannabis brand, according to recent BrightfieldContinue reading “VIVO Cannabis™ Announces Second Quarter 2020 Results”

VIVO CANNABIS™ Expands Cultivation and Processing Capacity

– VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) today announced its wholly-owned subsidiary, Canna Farms Limited (“Canna Farms“), has received all necessary Health Canada approvals to commence operations in its Phase 5 expansion, and that its wholly-owned subsidiary, ABcann Medicinals Inc. (“NCC“), has begun commercial production in its ethanol extraction suite. Facility Expansion Approval in Hope,Continue reading “VIVO CANNABIS™ Expands Cultivation and Processing Capacity”

MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence Sales

Large shipment of 35,000 units of formulated finished products and bulk extract completed to MPL Australia to support commencement of sales revenue  — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its subsidiary, MediPharm Labs Australia Pty.Continue reading “MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence Sales”